Nu Skin's customer count fell 18%; Q4 revenue is projected at $310 million to $340 million.

Nu Skin Enterprises reported Q3 2026 revenue within guidance, but customer count fell 18%. Q4 revenue is projected at $310M-$340M. CEO Ryan Napierski cited strategic execution amid challenges. The company will host a conference call for investors.

Original reporting
Published Nov 5, 2026, 9:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 10:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NUS
Bearish
high confidence
Mentioned
$NUS
Relevance
7/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$NUSBearishMed
01

Why it matters

The earnings release introduces fresh data on customer attrition and modest guidance, which could trigger a sell‑off.

02

Market read

First‑report earnings for a small‑cap consumer‑goods firm; likely to affect its stock more than the broader market.

03

What to watch

Potential upside from new product launches or expansion in emerging markets not reflected in the short‑term guidance.

Relevance 7/10Novelty 8/10Timing: after‑hours today

Background

Nu Skin Enterprises Inc. (NYSE: NUS) reported Q3 2026 results, noting an 18% decline in paid affiliates and provided Q4 revenue guidance of $310‑$340 million.

Company-level read

Ticker impact

$NUSBearishHigh confidence
Context

Q3 earnings released with 18% drop in customers and Q4 revenue guidance of $310M-$340M.

Expected impact

likely downside as market prices in weaker demand and modest outlook

Evidence & confidence

First‑report earnings with lower‑than‑expected customer metrics and limited guidance typically trigger sell pressure.

Market effects

beauty and wellness direct‑selling sector may see broader scrutiny on customer retention metrics.

U.S. and China markets could react as Nu Skin operates in both regions.

Limited to niche consumer‑goods segment; unlikely to move broader indices.

Counterpoint

If the company can stabilize affiliate recruitment, the stock may rebound on long‑term growth potential.

Key entities

  • Nu Skin Enterprises Inc.

    U.S. listed direct‑selling beauty and wellness company.

Related articles

$NUSMed

Nu Skin (NUS) Q3 2026 Earnings Call Transcript

Nu Skin (NUS) reported Q3 2026 revenue of $311M, with adjusted EPS of $0.10. The company highlighted a 10% scan-to-purchase conversion rate and 3% year-to-date sales growth for LifePak. Nu Skin plans to launch innovations in anti-aging and women's health mid-2027 and is preparing for India's market entry in early 2027. The company is restructuring to improve efficiency and profitability, with a focus on East-West market alignment.

$NUSHigh

Nu Skin: Q3 Earnings Snapshot

Nu Skin Enterprises (NUS) reported a Q3 loss of $742,000, or 2 cents per share. Adjusted earnings were 10 cents per share. Revenue was $311 million. The company forecasts Q4 EPS of 11-21 cents and full-year EPS of 55-65 cents.

$NUSMed

Nu Skin Enterprises Q3FY26 Results: Revenue $311M, EPS $0.10

Nu Skin Enterprises reported Q3FY26 revenue of $311M and adjusted EPS of $0.10, within guidance. Full-year sales outlook lowered to $1.26B-$1.29B, below consensus. Gross margin declined to 65% from 70.5%. Q4 revenue expected at $310M-$340M, EPS at $0.11-$0.21. Company ranked No. 1 in beauty and wellness devices by Euromonitor.

$NUSMed

Nu Skin Enterprises Reports Third Quarter Earnings

NU SKIN ENTERPRISES, INC. (NUS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Third Quarter Earnings PROVO, Utah — Nov. 5, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter revenue within its guidance range. Executive Summary Q3 2026 vs. Prior-year Quarter Revenue $311.0